Cracking the diversity of sweet drugs

Sharon Yehuda; Vered Padler-Karavani

doi:10.1038/s41589-024-01755-6

Cracking the diversity of sweet drugs

Sharon Yehuda, Vered Padler-Karavani

The Shmunis School of Biomedicine and Cancer Research

Tel Aviv University

Research output: Contribution to journal › Comment/debate

Abstract

Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.

Original language	English
Pages (from-to)	1397-1398
Number of pages	2
Journal	Nature Chemical Biology
Volume	20
Issue number	11
DOIs	https://doi.org/10.1038/s41589-024-01755-6
State	Published - Nov 2024

All Science Journal Classification (ASJC) codes

Molecular Biology
Cell Biology

Access to Document

10.1038/s41589-024-01755-6

Cite this

@article{99aab201b88c4a7d894ced2ff0a29d67,

title = "Cracking the diversity of sweet drugs",

abstract = "Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.",

author = "Sharon Yehuda and Vered Padler-Karavani",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2024.",

year = "2024",

month = nov,

doi = "10.1038/s41589-024-01755-6",

language = "الإنجليزيّة",

volume = "20",

pages = "1397--1398",

journal = "Nature Chemical Biology",

issn = "1552-4450",

publisher = "Nature Research",

number = "11",

}

TY - JOUR

T1 - Cracking the diversity of sweet drugs

AU - Yehuda, Sharon

AU - Padler-Karavani, Vered

N1 - Publisher Copyright: © Springer Nature America, Inc. 2024.

PY - 2024/11

Y1 - 2024/11

N2 - Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.

AB - Characterization of the heterogeneity in the glycosylation of biotherapeutics is crucial for drug development but challenging. Now, an approach allows the rapid analysis of the glycosylation of intact glycoproteins, without prior processing or separation, enabling the study of glycan composition and quality assessment of any glycoprotein drug.

UR - http://www.scopus.com/inward/record.url?scp=85207213590&partnerID=8YFLogxK

U2 - 10.1038/s41589-024-01755-6

DO - 10.1038/s41589-024-01755-6

M3 - تعليقَ / نقاش

C2 - 39448845

SN - 1552-4450

VL - 20

SP - 1397

EP - 1398

JO - Nature Chemical Biology

JF - Nature Chemical Biology

IS - 11

ER -

Cracking the diversity of sweet drugs

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this